Updated Jul 16, 2026
Kuo Minnie has filed 1 SEC Form 4 filing across 1 company in the last 90 days — selling. Lifetime open-market sales: $9K.

Minnie Kuo is the Chief Operating Officer of Pliant Therapeutics, Inc. (PLRX). The SEC filing with CIK 0002101360, dated 2026-01-23, lists her as COO and shows no equity purchases or sales (total purchases $0, total sales $0) across one filing. Pliant Therapeutics is a clinical-stage biopharmaceutical company focused on developing therapies for fibrosis and related diseases.
| Role | Chief Operating Officer |
|---|---|
| Notability | 35/100 |
| Date | Ticker | Company | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-01-23 | PLRX | PLIANT THERAPEUTICS, INC. | S — Open-market sale [10b5-1] | 6.9K | $1.28 | $9K |
Minnie Kuo is the Chief Operating Officer of Pliant Therapeutics, Inc. (PLRX). The SEC filing with CIK 0002101360, dated 2026-01-23, lists her as COO and shows no equity purchases or sales (total purchases $0, total sales $0) across one filing. Pliant Therapeutics is a clinical-stage biopharmaceutical company focused on developing therapies for fibrosis and related diseases.…
1 primary Form 4 filings in the last 90 days, covering 1 company.
Recorded transactions: 0 open-market purchases () and 1 open-market sales ($9K) across all tracked filings.
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Open the live Kuo Minnie profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.